We and our partners use cookies and other tracking technologies to collect data relating to you to perform analytics, improve your experience of using our website, provide you with personalized ads and content based on your interactions with these and other websites and allow you to share content on social media. By clicking “Accept All Cookies”, you consent to this and to the sharing of this data with our partners. You can change your consent preferences at any time in the “Cookie Settings” section at the bottom of our website. Review our Cookie Notice to learn more about our practices.
DURAClone IM Dendritic Cell
Dendritic cells (DCs) can be separated in two main subsets, myeloid DCs and plasmacytoid DCs. The DURAClone IM Dendritic Cell panel discriminates leukocyte-lineage positive cells and identifies plasmacytoid dendritic cells and 3 major subsets of myeloid dendritic cells. It utilizes dry reagent technology that confers workflow improvements.
- Panel of 12 markers in fluorochrome combinations that provide robust population identification, including CD1c, CD11c, CD16, CD45, CD123, Clec9A, HLA-DR and lineage exclusion markers CD3, CD14, CD19, CD20, CD56 (referred to as LIN)
- Pre-formulated antibody panel in a unitized assay eliminating antibody cocktailing
- 25 tests per kit including 3 compensation kits with lot matched tandem dyes
For Research Use Only. Not for use in diagnostic procedures.
Features
Expert Panels
- Proven marker combination to identify dendritic cell subtypes
- Open channels to add drop-in markers to modify for different research questions
- Designed for assay precision and lot-to-lot consistency
Efficiency
- Eliminate time spent in titrating different antibody lots
- Avoid waste that comes from preparing cocktail master mix
- Simplify inventory management
Consistency
- Unitized assays eliminate error prone pipetting steps
- Includes lot matched tandem dyes for compensation controls for improved accuracy
- Dry format maintains reagent performance better than liquid under stress conditions
Easy to Use
- Ready to use assay with verified panel design
- Includes sample preparation and staining procedure
- Streamlined workflow, just add sample, incubate, wash and acquire
Explore DURAClone IM Dendritic Cell Models
Technical Documents
Didn't find what you are looking for? For more results click
here.
Related Parts
DURAClone IM Count Tube, 25 Tests, RUO
The DURAClone IM Count is used for enumeration of CD45+ cells in whole blood while simultaneously differentiating live and dead cells.
ViaKrome 808 Fixable Viability Dye
The ViaKrome 808 Fixable Viability Dye is a thiol reactive fluorescent dye that covalently binds free thiol present on cellular proteins at a neutral pH.
VersaLyse Lysing Solution, 100 Tests, RUO
VersaLyse Lysing Solution is a reagent used to lyse red blood cells from any biological fluid and, in particular, to lyse erythrocytes from whole blood. VersaLyse is a highly specific, very gentle lysing solution, suitable for applications such as immunophenotyping, cell sorting, activation or cell culture. It is designed for use in flow cytometry and facilitates obtaining highly discriminative scattergrams whatever the type of flow cytometer used. VersaLyse is a versatile reagent which may be used in lyse / wash, wash / lyse and lyse / no-wash procedures with undiluted or diluted samples.
The histograms are dual-parameter light scatter histograms (FS versus SS) of a normal K3EDTA anticoagulated blood sample lysed with VersaLyse Lysing Solution (No-wash procedure).
IOTest 3 Fixative Solution, 100-200 Tests, RUO
The IOTest3 Fixative Solution allows whole blood or bone marrow specimen preparation by fixing the cell suspension after erythrolysis during immunophenotyping procedures. At least one wash is required between the lysis and the fixation steps. The IOTest3 Fixative Solution is optimized to work in combination with the IOTest3 Lysing Solution. IOTest Fixative Solution is a formaldehyde-based fixative solution designed for flow cytometry. This reagent is provided as a concentrated solution in PBS.
